Spend £150 for 20% Off | Spend £500 for 30% Off
Spend £150 for 20% Off | Spend £500 for 30% Off
£19.90
| Volume Pricing | |
|---|---|
| Spend £150+ (20% off) | £23.12 |
| Spend £500+ (30% off) | £20.23 |
Spending over £1000? Email us your order and we will custom price.
Free shipping on orders over £20
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY.
The products offered on this website are furnished for in-vitro studies only. In-vitro studies are performed outside of the body. These products are not medicines or drugs and have not been approved to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden.
PEG-MGF is a pegylated derivative of Mechano Growth Factor (MGF), a splice variant of insulin-like growth factor-1 (IGF-1) associated with mechanical stress–responsive signalling in muscle and other tissues. PEGylation is employed to modify physicochemical properties such as stability and resistance to enzymatic degradation in experimental systems.
In biochemical and cellular research models, PEG-MGF is used to investigate IGF-1 receptor–related signalling, satellite cell activation pathways, and growth factor–mediated intracellular responses. Experimental studies focus on receptor interaction dynamics, downstream signalling cascades, and comparative behaviour relative to non-pegylated IGF-1 variants. Observed effects are dependent on experimental design, concentration, and model system, and are used to explore signalling mechanisms rather than defined physiological or clinical outcomes.
• Investigation of IGF-1–related signalling and muscle mechanotransduction pathways
• Study of growth factor stability and PEGylation effects in vitro
• Comparative research involving IGF-1 splice variants and modified peptides
• Use as a reference compound in growth factor and peptide modification studies
• Handle using appropriate peptide-handling procedures
• Reconstitute in sterile water or suitable buffered aqueous solution
• Gently swirl to dissolve; do not vortex
• Filter sterilize if required (e.g. 0.22 µm) immediately prior to use
• Aliquot and store reconstituted solutions at –20 °C (or lower)
• Avoid repeated freeze–thaw cycles
Purity: Manufactured to specification (research grade)
Appearance: White to off-white lyophilised powder
Peptide Type: Pegylated MGF (IGF-1 Ec analogue)
Molar Weight:~2867.2 g/mol
Solubility: Water, buffered aqueous solutions
Storage: –20 °C, desiccated, protected from light
Pack Size: Typically 2 mg
• Experimental behaviour of PEG-MGF is influenced by receptor expression, concentration, and model system
• PEGylation may alter receptor binding kinetics and intracellular signalling profiles
• Buffer composition and pH may affect peptide stability
• Appropriate controls are recommended to distinguish PEG-related effects from peptide-specific activity
• Intended strictly for laboratory research use; not for human or veterinary application
